| Structure | Chemical Name | CAS | MF | 
|  | Dapagliflozin Impurity 165 | 342043-51-0 | C18H18O4 | 
|  | 3'-Desethoxy Drotaverine Hydrochloride | 85475-87-2 | C22H28ClNO4 | 
|  | (S)-dimethyl 2-(4-(4-oxobutyl)benzamido)pentanedioate | 1081974-98-2 | C18H23NO6 | 
|  | Peramivir Impurity 38 |  |  | 
|  | 2-O-cinnamoyl-beta-D-glucose |  |  | 
| ![(3S)-3-((S)-1-oxo-3a,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-2(3H)-yl)quinuclidine 1-oxide](../) | (3S)-3-((S)-1-oxo-3a,4,5,6-tetrahydro-1H-benzo[de]isoquinolin-2(3H)-yl)quinuclidine 1-oxide |  |  | 
|  | 2-(4-hydroxy-1-methyl-7-phenoxy-5,6,7,8-tetrahydroisoquinoline-3-carboxamido)acetic acid |  |  | 
|  | 6-HYDROXYLAMINOURACIL | 20555-88-8 | C4H5N3O2 | 
|  | 7-PACE Impurity 1 |  |  | 
|  | 1-(3-Cyanopyridyl-2)-2-Phenyl-4-Methylpyperazine | 61337-88-0 | C17H18N4 | 
|  | Ertapenem Impurity E(USP) |  |  | 
|  | Pyrazinecarboxaldehyde, trimethyl- (9CI) | 186534-02-1 | C8H10N2O | 
| ![Acetamide, N-[4-[(2R)-3-cyano-2-methyl-1-oxopropyl]phenyl]-](../cas/20210305/gif/2428573-45-7.gif) | Acetamide, N-[4-[(2R)-3-cyano-2-methyl-1-oxopropyl]phenyl]- | 2428573-45-7 | C13H14N2O2 | 
| ![4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid](../cas/20211123/gif/2469039-29-8.gif) | 4-[6-(2-Chloroethyl)-3,6,7,8-tetrahydro-3-methylimidazo[4,5-h][1,4]benzothiazin-2-yl]butanoic acid | 2469039-29-8 | C16H21Cl2N3O2S | 
| ![1-(2-Methoxyphenyl)-4-{3-[4-(2-methoxyphenyl)piperazin-1-yl] propyl}piperazine](../) | 1-(2-Methoxyphenyl)-4-{3-[4-(2-methoxyphenyl)piperazin-1-yl] propyl}piperazine |  |  | 
|  | D-erythro-Pent-4-enose, 4,5-dideoxy-2,3-O-(1-methylethylidene)- (9CI) | 155934-55-7 | C8H12O3 | 
|  | Isavuconazole Impurity 41 |  |  | 
| ![Carbamic acid, N-benzoyl-N-(2-phenylethyl)-, (2R)-1-azabicyclo[2.2.2]oct-2-yl ester](../cas/20210305/gif/1798817-91-0.gif) | Carbamic acid, N-benzoyl-N-(2-phenylethyl)-, (2R)-1-azabicyclo[2.2.2]oct-2-yl ester | 1798817-91-0 | C23H26N2O3 | 
|  | NA |  |  | 
|  | NA |  |  | 
|  | NA |  |  | 
|  | Cetrorelix Impurity 12 |  |  | 
|  | Cetrorelix Impurity 5 (6-D-Orn) |  |  | 
|  | Tenofovir impurity EE |  |  | 
|  | Peramivir Intermediate Impurity 35 |  |  | 
|  | Peramivir Intermediate Impurity 40 |  |  | 
|  | Alvatrombopag Impurity 999 |  |  | 
|  | NA |  |  | 
|  | Palonosetron impurity 30XH |  |  | 
|  | Pazopanib ImpurityABCDEFGHJKL |  |  | 
|  | 1-(4-(2-Dimethylamino)-2-ethoxyphenyl butanone | 68047-07-4 | C20H25NO2 | 
|  | Vonoprazan-050-C4H4O4 | 928325-69-3 | C21H19ClFN3O6S | 
|  | Crisaborole Impurity 45 | 1785498-37-4 | C7H6Br2O | 
|  | Sugammadex Impurity 26(Org199129-1) | 2412953-06-9 |  | 
|  | Gadobutrol Impurity A |  |  | 
|  | Levocarnitine EP Impurity A(Z) |  |  | 
|  | Penicillin impurity E |  |  | 
| ![4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1,1-bis((5-methylpyridin-3-yl)methyl)piperidin-1-ium](../) | 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1,1-bis((5-methylpyridin-3-yl)methyl)piperidin-1-ium |  |  | 
|  | Bisoprolol Impurity 34 |  |  | 
|  | Flomoxef Impurity I |  |  | 
|  | Ampicillin Impurity C2 |  |  | 
|  | Tegoprazan Impurity 13 |  |  | 
|  | Nirmatrelvir Impurity 6 |  |  | 
|  | Bumetanide Impurity 25 |  |  | 
|  | Rocuronium Bromide Impurity 16 、17、18 |  |  | 
|  | Roxadustat Impurity 15 |  |  | 
|  | (1S,3S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H- pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,4,6,7,8,8a-octahydronaphthalen- 1-yl 2,2-dimethylbutanoate | 132487-01-5 | C25H40O5 | 
|  | 3-(hydroxy(2-methyl-1H-imidazol-1-yl)methyl)-9-(hydroxymethyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one |  |  | 
|  | Perospirone Impurity 18 |  |  | 
|  | Perospirone Impurity 3 | 1002359-81-0 | C8H11NO2 | 
|  | Dolutegravir Impurity 13(Sodium Salt) |  |  | 
|  | Paxlovid Impurity 10 |  |  | 
|  | Fondaparinux sodium impurity 4 |  |  | 
|  | Ampicillin Impurity W |  |  | 
| ![2-(5-Acetyl-2-ethoxyphenyl)-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one](../cas/20210111/gif/358390-43-9.gif) | 2-(5-Acetyl-2-ethoxyphenyl)-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4(1H)-one | 358390-43-9 | C19H22N4O3 | 
|  | Empagliflozin Impurity 80 |  |  | 
|  | Empagliflozin Impurity 92 |  |  | 
|  | Iohexol Impurity N |  |  | 
|  | Pitavastatin 5-Oxo Impurity  Calcium Salt | 2180095-22-9 | C25H24CaFNO4 | 
|  | 1-(2-bromo-3,5-dihydroxyphenyl)ethanone | 2092614-65-6 | C8H7BrO3 | 
|  | Lenvatinib impurity LFZZ-18 |  | C11H8Cl2N2O2 | 
|  | Rosuvastatin Impurity 121 | 140164-51-8 | C10H18O5 | 
|  | Brivaracetam Impurity 38 |  |  | 
|  | Isavuconazole Impurities 04 |  |  | 
|  | Ticagrelor Impurity 119 |  |  | 
|  | Ticagrelor Impurity 118 |  |  | 
|  | D-erythro-Hexonic acid, 2,4-dideoxy-3,5-O-(1-methylethylidene)-, acetate (9CI) | 402508-35-4 | C11H18O6 | 
| ![L-Alanine, 3-[(S)-(carboxymethyl)sulfinyl]-](../cas/20200611/gif/112246-66-9.gif) | L-Alanine, 3-[(S)-(carboxymethyl)sulfinyl]- | 112246-66-9 | C5H9NO5S | 
| ![2-Propanone, 1-[4,5-dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]-](../cas/20200611/gif/1902955-67-2.gif) | 2-Propanone, 1-[4,5-dihydro-2-(4-methyl-1-piperazinyl)-4-thioxo-3H-1,5-benzodiazepin-3-ylidene]- | 1902955-67-2 | C17H20N4OS | 
| ![3(2H)-Pyridazinone, 6-[4-(ethylamino)phenyl]-4,5-dihydro-5-methyl-](../cas/20200611/gif/52240-42-3.gif) | 3(2H)-Pyridazinone, 6-[4-(ethylamino)phenyl]-4,5-dihydro-5-methyl- | 52240-42-3 | C13H17N3O | 
| ![Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]-](../cas/20200611/gif/938143-02-3.gif) | Benzoic acid, 4-[[4-(aminocarbonyl)-1-piperidinyl]methyl]- | 938143-02-3 | C14H18N2O3 | 
|  | 1-(4-methylbenzyl)-1,4,8,11-tetraazacyclotetradecane tetrahydrochloride |  |  | 
|  | 2,4-bis(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole |  |  | 
|  | 2-((4R,6S)-6-((2-((4R,6S)-6-(hydroxymethyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetoxy)methyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetic acid |  |  | 
|  | 1,3-bis(4-((E)-3-methoxy-3-oxoprop-1-en-1-yl)benzyl)-1H-imidazol-3-ium bromide |  |  | 
|  | Crisaborole intermediate | 1187230-70-1 | C14H14BNO3 | 
| ![Glycine, (2R)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-2-phenylglycyl-2-[(2S,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]-, (2R)-](../cas/20210111/gif/1449784-97-7.gif) | Glycine, (2R)-N-[(4-ethyl-2,3-dioxo-1-piperazinyl)carbonyl]-2-phenylglycyl-2-[(2S,4S)-4-carboxy-5,5-dimethyl-2-thiazolidinyl]-, (2R)- | 1449784-97-7 | C23H29N5O8S | 
| ![6-Quinolinecarboxamide, 4-[(2-chloro-4-hydroxyphenyl)amino]-7-methoxy-](../cas/20210111/gif/2380197-89-5.gif) | 6-Quinolinecarboxamide, 4-[(2-chloro-4-hydroxyphenyl)amino]-7-methoxy- | 2380197-89-5 | C17H14ClN3O3 | 
|  | 1-Pyrrolidineacetic acid, α-ethyl-2-oxo-4-propyl-, methyl ester, (4R)- | 930123-52-7 | C12H21NO3 | 
|  | Traxipide impurity |  |  | 
| ![Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-, methyl ester](../cas/20210305/gif/1181267-38-8.gif) | Benzeneacetic acid, 4-[2-[4-[1-(2-ethoxyethyl)-1H-benzimidazol-2-yl]-1-piperidinyl]ethyl]-α,α-dimethyl-, methyl ester | 1181267-38-8 | C29H39N3O3 | 
| ![Benzenemethanol, 4-[2-(1-methylethoxy)ethoxy]-](../cas/20210111/gif/1039828-27-7.gif) | Benzenemethanol, 4-[2-(1-methylethoxy)ethoxy]- | 1039828-27-7 | C12H18O3 | 
|  | Brivaracetam Impurity 7 HCl | 357338-46-6 | C13H27ClN2O3 | 
|  | Bisacodyl Impurity 1 | 13004-51-8 | C18H15NO2 | 
|  | Vecuronium Bromide ImpurityACDEFGHJKL |  |  | 
| ![Butanedioic acid, 2-[[2-methyl-1-(phenylmethyl)-1H-imidazol-5-yl]methylene]-, 1-ethyl ester, (2E)-](../cas/20210111/gif/1640981-02-7.gif) | Butanedioic acid, 2-[[2-methyl-1-(phenylmethyl)-1H-imidazol-5-yl]methylene]-, 1-ethyl ester, (2E)- | 1640981-02-7 | C18H20N2O4 | 
|  | INDEX NAME NOT YET ASSIGNED | 2452300-94-4 | C21H25ClO8 | 
| ![1-Butanone, 1-(4-fluorophenyl)-4-[(6bS,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-](../cas/20200611/gif/1576240-15-7.gif) | 1-Butanone, 1-(4-fluorophenyl)-4-[(6bS,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]- | 1576240-15-7 | C24H28FN3O | 
| ![2-bromo-6-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile](../) | 2-bromo-6-(6'-oxo-1'-phenyl-1',6'-dihydro-[2,3'-bipyridin]-5'-yl)benzonitrile |  |  | 
|  | tert-butyl 2-((4R,6S)-6-((E)-2-(4-(2-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate |  |  | 
| ![methyl (3aR,4S,6R,6aS)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3- yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate](../) | methyl (3aR,4S,6R,6aS)-4-((tert-butoxycarbonyl)amino)-3-(pentan-3- yl)-3a,5,6,6a-tetrahydro-4H-cyclopenta[d]isoxazole-6-carboxylate |  |  | 
| ![3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo-, hydrochloride (1:)](../cas/20211123/gif/570403-05-3.gif) | 3-Pyridinecarboxamide, 5-chloro-N-[4-(4-chloro-2-thienyl)-5-(4-cyclohexyl-1-piperazinyl)-2-thiazolyl]-1,6-dihydro-6-oxo-, hydrochloride (1:) | 570403-05-3 | C23H26Cl3N5O2S2 | 
|  | Avatrombopag Impurity 49 |  |  | 
|  | Avatrombopag Impurity 56 |  |  | 
|  | Pterosin A-2-O-glucoside |  |  | 
| ![2-(4-(2-(4-(1-(2-hydroxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid](../cas/20181212/gif/cb49996366.gif) | 2-(4-(2-(4-(1-(2-hydroxyethyl)-1H-benzo[d]imidazol-2-yl)piperidin-1-yl)ethyl)phenyl)-2-methylpropanoic acid |  | C26H33N3O3 | 
| ![2-(4-ethylpiperazin-1-yl)-4-(4-methoxyphenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine](../cas/20181212/gif/cb510019552.gif) | 2-(4-ethylpiperazin-1-yl)-4-(4-methoxyphenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine |  | C24H33N3O | 
|  | Rosuvastatin Impurity 163 |  |  | 
|  | Rosuvastatin Impurity 150 |  |  | 
| ![1-[2-(2,4-difluorophenyl)-2,3-epoxypropyl]-1h-1,2,4-triazole](../cas/gif/86386-76-7.gif) | 1-[2-(2,4-difluorophenyl)-2,3-epoxypropyl]-1h-1,2,4-triazole | 86386-76-7 | C11H9F2N3O |